News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
David Planchard Highlights Promise and Access Challenges of HER2-TKIs for HER2-Mutant NSCLC
David Planchard/oncostream.com
May 1, 2025, 16:11

David Planchard Highlights Promise and Access Challenges of HER2-TKIs for HER2-Mutant NSCLC

David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post on LinkedIn about a paper he co-authored with colleagues published in NEJM.

“After ADCs, HER2-TKIs arrive…impressive clinical activity and tolerance! Things are moving fast, but access is still difficult in Europe outside a clinical trial…unfortunately for our HER2-mutant patients!”

Title: Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer

Authors: John Heymach, Gerrina Ruiter, Myung-Ju Ahn, Nicolas Girard, Egbert Smit, David Planchard, Yi-Long Wu, Byoung Chul Cho, Noboru Yamamoto, Joshua Sabari, Yanqiu Zhao, Hai-Yan Tu, Kiyotaka Yoh, Ernest Nadal, Behbood Sadrolhefazi, Maren Rohrbacher, Ute von Wangenheim, Sabina Eigenbrod-Giese, Jon Zugazagoitia.

You can read the Full Article on NEJM.

David Planchard Highlights Promise and Access Challenges of HER2-TKIs for HER2-Mutant NSCLC

More posts featuring David Planchard.

ADCs Behbood Sadrolhefazi Byoung Chul Cho cancer David Planchard Egbert Smit Ernest Nadal Gerrina Ruiter Hai-Yan Tu HER2-TKIs John Heymach Jon Zugazagoitia Joshua Sabari Kiyotaka Yoh Lung cancer Maren Rohrbacher Myung-Ju Ahn Nicolas Girard Noboru Yamamoto non small cell lung cancer NSCLC OncoDaily Oncology Sabina Eigenbrod-Giese targeted therapy Ute von Wangenheim Yanqiu Zhao Yi-Long Wu Zongertinib
Special Coverage
Blog
May 21, 2025, 21:13
2025 Chinese Congress on Holistic Integrative Oncology (CCHIO)
Insight
May 21, 2025, 19:15
Haydeé Verduzco-Aguirre shared study on 20-year breast cancer trends and treatment gaps in São Paulo
Insight
May 21, 2025, 19:10
Samuel Hume: Top 5 advances in medicine this week
Insight
May 21, 2025, 19:04
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology
Career
May 21, 2025, 17:46
Sharon Kapambwe Has Been Appointed as Technical Officer for Cancer Control at WHO Uzbekistan
Opinion
May 21, 2025, 17:41
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study